Salmeterol and fluticasone Genetic DPI inhaler usability study
Research type
Research Study
Full title
Salmeterol and fluticasone Genetic DPI inhaler usability study
IRAS ID
201643
Contact name
Richard Featherstone
Contact email
Sponsor organisation
Genetic SpA
Clinicaltrials.gov Identifier
NA, None
Duration of Study in the UK
0 years, 0 months, 8 days
Research summary
This is a usability study of the instructions for two dry powder inhalers. The purpose is to evaluate how well patients adhere to the instructions when using the inhalers.
60 participants will be enrolled in England: 15 children aged 4-12 years with asthma, 15 adolescents aged 13-17 years with asthma, 15 adults with asthma and 15 adults with COPD.
Each participant will be given two empty inhalers (Seretide Accuhaler and a new inhaler not available in the UK), and will be asked to follow the instructions to simulate using it. An observer will note how many errors they make in their inhaler technique. The results will not be shared with the participant.
Each participant will also be asked to inhale through an In-Check device to measure their inspiratory flow rate. The results will not be shared with the participant.REC name
South West - Central Bristol Research Ethics Committee
REC reference
16/SW/0064
Date of REC Opinion
16 Mar 2016
REC opinion
Further Information Favourable Opinion